Skip to content
    UI Investissement logo

    UI Investissement

    Paris, FranceFounded 1967

    UI Investissement is an independent French private equity firm founded in 1967 and headquartered in Paris. It invests in unlisted SMEs and mid-cap companies (ETIs) across France, providing capital for development, transmission (LBO), innovation, and consolidation across sectors including healthcare, agribusiness, industry, and services.

    Deal activity decreased year-over-year (2 deals in the last 12 months vs 6 prior). Average disclosed round size is $28.0M (across 5 rounds with reported amounts).

    Find people at UI Investissement on Goldilocks AI

    Portfolio

    54

    Fund Size

    —

    Top Stage

    Unknown

    Last 12 Mo

    2

    Team

    Alexandre Benezeth

    Alexandre Benezeth

    Directeur d'investissement

    Alexandre Clauzet

    Alexandre Clauzet

    Directeur d'investissement santé

    Alexis Calchera

    Alexis Calchera

    Analyste

    Alexis de Seze

    Alexis de Seze

    Directeur d'investissement

    Alexis Valles

    Alexis Valles

    Comptable

    Alix Ridet

    Alix Ridet

    Directrice d'investissement

    Anne-Lise Flandin

    Anne-Lise Flandin

    Office manager

    Antoine Bertin

    Antoine Bertin

    Directeur associé

    Arnaud Grandclerc

    Arnaud Grandclerc

    Directeur d’investissement

    Aurélia Bojmal

    Aurélia Bojmal

    Directrice d'investissement

    Aymeric Balmont

    Aymeric Balmont

    Secrétaire général

    Barbara Lezier

    Barbara Lezier

    Directrice juridique & administration des fonds

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    65 investments
    CompanyRoundAmountDate
    Axoltis Pharma logoAxoltis PharmaSeries A—Dec 2025
    Exeliom Biosciences logoExeliom BiosciencesSeries A—Oct 2025
    DDillicoSeed—Jul 2025
    FFungu'itUnknown—Jun 2025
    Deepull logoDeepullSeries C—Apr 2025
    DDEEPULL DIAGNOSTICS, S.L.Series C—Apr 2025
    Coave Therapeutics logoCoave TherapeuticsSeries A$33MJan 2025
    Frerejean Frères logoFrerejean FrèresUnknown—Jan 2025
    Axoltis Pharma logoAxoltis PharmaSeries A—Jan 2025
    Coave Therapeutics logoCoave TherapeuticsSeries A$32MJan 2025
    Cintoo logoCintooSeries B—Nov 2024
    OOverseed BiotechSeries A—Jul 2024
    Latitude logoLatitudeSeries B$30MJan 2024
    Latitude logoLatitudeSeries B$30MJan 2024
    Diabeloop logoDiabeloopSeries C—Jan 2024
    BBrenus PharmaSeries A—Jan 2024
    ACWA ROBOTICS logoACWA ROBOTICSUnknown—Jan 2024
    UUltrawattSeed—Jan 2024
    MECAWARE logoMECAWARESeries A—Oct 2023
    Exeliom Biosciences logoExeliom BiosciencesSeries A—Jul 2023
    NNextbiotixSeries A—Jul 2023
    EExeliom BiosciencesSeries A—Jul 2023
    RECYC’ELIT logoRECYC’ELITSeed—Jan 2023
    OOrikioSeries A—Jan 2023
    Exeliom Biosciences logoExeliom BiosciencesSeries A—Jan 2023
    Page 1 of 3

    Top Co-Investors

    Last updated: 20 October 2026